BridgeBio Oncology Therapeutics, Inc. (BBOT) Gross margin
BridgeBio Oncology Therapeutics, Inc. (BBOT) gross margin by fiscal year — reported gross profit divided by reported revenue.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to BBOTSource: SEC XBRL filings · For reference only · Not investment advice
More BBOT financial trends
BBOT RevenueBBOT Net incomeBBOT Net marginBBOT Gross profitBBOT Operating incomeBBOT Operating marginBBOT Operating cash flowBBOT Free cash flowBBOT Capital expendituresBBOT Return on equityBBOT Stock buybacksBBOT Dividends paidBBOT Total assetsBBOT Total liabilitiesBBOT Shareholders’ equityBBOT overview →